Story

Cirrus Logic, Insulet, Trade Desk Face Steep Sell-Offs Amid Divergent Outlooks

ENTHMSVIIDZHZH-TWJAKOHI
Aug 11, 20262 min read
Cirrus Logic, Insulet, Trade Desk Face Steep Sell-Offs Amid Divergent Outlooks
Text size
Background

Recent market volatility has sent shares of semiconductor firm Cirrus Logic (CRUS), medical device maker Insulet (PODD), and ad-tech platform The Trade Desk (TTD) tumbling. According to an analysis from Investing.com, while all three stocks appear oversold, the underlying reasons for their declines present distinctly different risk profiles for investors.

Cirrus Logic: A Disproportionate Response

Shares of Cirrus Logic have fallen 19% in the past month, a move that the source material suggests is an overreaction to its latest earnings report. The analog semiconductor company reported first-quarter EPS of $1.84, which beat estimates, but its revenue of $459.7 million fell just short of the $460.3 million consensus.

Despite the minor revenue miss, the company's fundamentals remain strong, according to Investing.com's data. Key metrics include:

  • Price-to-Earnings (P/E) Ratio: 14.2x
  • Return on Equity (ROE): 20.9%
  • Debt-to-Equity: 6%

A Relative Strength Index (RSI) of 28.5 indicates the stock is in technically oversold territory. Investing.com's fair-value model estimates a potential upside of 39% to an intrinsic value of $169.36, based on the view that the market punishment exceeded the scale of the revenue miss.

Insulet: Caught in Sector Headwinds

Sample IUX Markets – In-articleAd

Insulet has declined 11.4% over the past month, even after posting strong operational results. The company, which produces the Omnipod insulin delivery system, reported revenue growth of 29.4% and a return on equity of 26%.

The stock's decline appears linked to a broader, sector-wide pullback in medical device stocks rather than company-specific issues. With its strong growth and recurring revenue characteristics, Investing.com's fair-value model suggests a 32.3% upside to $185.28, positioning the sell-off as a potential opportunity in a fundamentally sound business.

The Trade Desk: A High-Risk Downturn

The most severe situation is at The Trade Desk, whose stock has plummeted 64.7% year-to-date. The programmatic advertising company missed second-quarter revenue estimates and issued third-quarter guidance that implies its first-ever year-over-year revenue decline of approximately -12%.

The downturn is attributed to sharp spending pullbacks from consumer-packaged goods (CPG) and automotive advertisers, which constitute 25% of its business. Multiple analysts have slashed their price targets in response. However, Investing.com's analysis notes a contrarian case, citing a deeply oversold RSI of 29.2, a strong balance sheet with more cash than debt, and thriving international segments. The source's fair-value model calculates a potential upside of 68.9%, but this is heavily contingent on a cyclical recovery in the ad market that has not yet materialized, making it a high-risk proposition.

Read next

More on Stocks
Back to latest news

LATEST